Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Epigenetic dysregulation, which leads to the alteration of gene expression in the brain, is suggested as one of the key pathophysiological bases of ageing and neurodegeneration. Here we found that, in the late-stage familial Alzheimer's disease (FAD) mouse model, repressive histone H3 dimethylation at lysine 9 (H3K9me2) and euchromatic histone methyltransferases EHMT1 and EHMT2 were significantly elevated in the prefrontal cortex, a key cognitive region affected in Alzheimer's disease. Elevated levels of H3K9me2 were also detected in the prefrontal cortex region of post-mortem tissues from human patients with Alzheimer's disease. Concomitantly, H3K9me2 at glutamate receptors was increased in prefrontal cortex of aged FAD mice, which was linked to the diminished transcription, expression and function of AMPA and NMDA receptors. Treatment of FAD mice with specific EHMT1/2 inhibitors reversed histone hyper-methylation and led to the recovery of glutamate receptor expression and excitatory synaptic function in prefrontal cortex and hippocampus. Chromatin immunoprecipitation-sequencing (ChIP-seq) data indicated that FAD mice exhibited genome-wide increase of H3K9me2 enrichment at genes involved in neuronal signalling (including glutamate receptors), which was reversed by EHMT1/2 inhibition. Moreover, the impaired recognition memory, working memory, and spatial memory in aged FAD mice were rescued by the treatment with EHMT1/2 inhibitors. These results suggest that disrupted epigenetic regulation of glutamate receptor transcription underlies the synaptic and cognitive deficits in Alzheimer's disease, and targeting histone methylation enzymes may represent a novel therapeutic strategy for this prevalent neurodegenerative disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The diminished transcription of NMDA and AMPA receptors in late-stage AD mouse models has been linked to the EHMT1/2-mediated repressive histone methylation at their promoters 256.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [256]
In the citing paper
“Treatment of AD models with specific EHMT1/2 inhibitors reverses the increased H3K9me2 enrichment at genes involved in neuronal signaling (e.g. Grin2b encoding NR2B subunit and Gria2 encoding GluR2 subunit), restores glutamate receptor expression and excitatory synaptic function in PFC, and rescues the impaired recognition memory, working memory, and spatial memory 256 (Fig. 5).”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [256]
Citations
Cites
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
High-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845 · cited 1×
“histone modifying enzymes, which is associated with gene activation or repression (Barski et al., 2007; Heintzman et al., 2007).”
BackgroundSelf-citationThe Role of Chromatin during Transcription
Li, B., Carey, M., & Workman, J. L. (2007) · Cell · doi:10.1016/j.cell.2007.01.015 · Cited by 3,533
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 2×
“Genotyping were performed by PCR according to the manufacturer’s protocol (Oakley et al., 2006; Yoshiyama et al., 2007).”
BackgroundMethodHeintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A., et al. (2007) · Nature Genetics · doi:10.1038/ng1966 · Cited by 3,398 · cited 1×
“histone modifying enzymes, which is associated with gene activation or repression (Barski et al., 2007; Heintzman et al., 2007).”
BackgroundSelf-citationCellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663
Histone methylation: a dynamic mark in health, disease and inheritance
Greer, E. L., & Shi, Y. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3173 · Cited by 2,241
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“Excessive amyloid-b depresses excitatory synaptic transmission (Kamenetz et al., 2003), resulting in chronic activity deprivation.”
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
Popoli, M., Yan, Z., McEwen, B. S., & Sanacora, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3138 · Cited by 1,393
Self-citation
Research works printed but not linked: 1
- Sperfeld, 1999, FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation, Ann Neurol, 46, 708, 10.1002/1531-8249(199911)46:5<708::aid-ana5>3.0.co;2-k · doi:10.1002/1531-8249(199911)46:5<708::aid-ana5>3.0.co;2-k
Cited by
Items 101–171 of 171
Wei, B., Shi, Y., Yu, X., Cai, Y., Zhao, Y., Song, Y., Zhao, Z., Huo, M., Li, L., Gao, Q., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04244-y · Cited by 9
Huang, Q., Xiong, H., Tao, Z., Yue, F., & Xiao, N. (2021) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2021.104289 · Cited by 8
Natarajan, K., Eisfeldt, J., Hammond, M., Patra, K., Laffita‐Mesa, J. M., Andrade‐Talavera, Y., Birtele, M., Öijerstedt, L., Fisahn, A., Parmar, M., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01234-2 · Cited by 8
Histone demethylase PHF2 regulates inflammatory genes in Alzheimer’s disease
Yang, G., Ren, Y., Zhong, P., Patel, P., Chen, X.-Q., Wan, L., Lee, Y. H., Saleem, K., Feng, J., & Yan, Z. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03181-z · Cited by 7
Self-citationEpigenetic Inhibitors as Alzheimer’s Disease Therapeutic Agents
Yamashita, Y., Itoh, Y., Takada, Y., & Suzuki, T. (2024) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c23-00027 · Cited by 7
Li, J., Li, Y., Wang, Z., Yao, Y., Yao, D., Chen, K., & Xia, Y. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70511 · Cited by 7
Self-citationLi, L., Wu, Y., Dai, K., Wang, Q., Ye, S., Shi, Q., Chen, Z., Huang, Y.-C., Zhao, W., & Li, L. (2023) · Cell Insight · doi:10.1016/j.cellin.2023.100112 · Cited by 7
Clinical characteristics and genetic analysis of four pediatric patients with Kleefstra syndrome
Ren, R., Liu, Y., Liu, P., Zhao, J., Hou, M., Li, S., Chen, Z., & Yuan, A. (2024) · BMC Medical Genomics · doi:10.1186/s12920-024-02065-5 · Cited by 7
Wang, Y., Yue, S., Yang, F., Chen, L., Singh, A., Marciniak, M., Wei, W., & Wang, Z.-J. (2025) · Nature Communications · doi:10.1038/s41467-025-64585-7 · Cited by 6
Self-citationBellver‐Sanchís, A., Valle‐García, D., Barbaraci, C., Romero-Becerra, F., Singh, R. K., Jarné‐Ferrer, J., Vasilopoulou, F., Irisarri, A., Martínez-Fernández, C., Fafián-Labora, J. A., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.12.038 · Cited by 6
The Neuroepigenetic Landscape of Vertebrate and Invertebrate Models of Neurodegenerative Diseases
Sundaramoorthy, T. H., & Castanho, I. (2022) · Epigenetics Insights · doi:10.1177/25168657221135848 · Cited by 6
Neuroprotection in Alzheimer Disease
Jain, K. K. (2019) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-4939-9465-6_8 · Cited by 6
Potential connections between senescence and chemobrain: An early overview of literature
Melhem, N. Y., Qutifan, S., Alsalem, M., & Saleh, T. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102896 · Cited by 5
HMGCS2-dependent β-OHB/H3K9bhb ameliorates synaptic plasticity and cognition in Alzheimer’s disease
Yu, H., Wang, F., Yuan, J.-Q., Chen, J., Zhang, K.-Y., Jia, D., Gong, J., Mao, Y., Bi, S., Zhang, Y.-Q., et al. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01664-9 · Cited by 5
Fernández, G. R., Leiva, K., Bustos, F. J., & van Zundert, B. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01903-2 · Cited by 4
Ravnik, V., Jukič, M., Furlan, V., Maver, U., Rožanc, J., & Bren, U. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1611461 · Cited by 4
Hajar, M., Jayaprakash, P., Stark, H., & Sadek, B. S. (2026) · Scientific Reports · doi:10.1038/s41598-026-38481-z · Cited by 4
Yan, Y., Pan, Y., Lu, S., Kou, J., Chen, X., Zeng, W., Luo, D., Qiu, L., Zhang, H., & Chen, D. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251372945 · Cited by 4
Insights from RNA-Seq analysis of Alzheimer's data suggest upregulation of GPCRs
Chaudhary, A., Kushwah, S., Maurya, N. S., & Mani, A. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100921 · Cited by 4
Xiong, F., Li, C., Wang, Q., Geng, X., Yuan, Z., & Li, Z. (2023) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02107-0 · Cited by 3
The impact of sex on memory during aging and Alzheimer's disease progression: Epigenetic mechanisms
Scheinman, S. B., & Dong, H. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241288709 · Cited by 3
Patel, P. J., & Yan, Z. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251414887 · Cited by 3
Self-citationImpact of Neuroimmune System Activation by Adolescent Binge Alcohol Exposure on Adult Neurobiology
Macht, V. A., de Castro, S., & Vetreno, R. P. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-81908-7_9 · Cited by 2
Epigenetic Changes in Alzheimer’s Disease and Interventions for Therapy
Xu, M., Xiong, L., Qin, Z., Yu, X., Chen, T., Zhang, X., Jin, M., Wang, L., Cai, L., Wei, Y., et al. (2026) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s576404 · Cited by 2
Neurogenesis and the Epigenetic Landscape: Role of Histone Modifications and Chromatin Remodeling
Mengistu, D. Y., & Eskeziyaw, B. M. (2026) · Brain and Behavior · doi:10.1002/brb3.71223 · Cited by 2
Alzheimer’s Disease and Epigenetics
Örenay-Boyacıoğlu, S., Boyacıoğlu, O., & Döndü, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_172-1 · Cited by 2
Ghanbari, M., Khosroshahi, N. S., Alamdar, M., Abdi, A., Aghazadeh, A., Feizi, M. A. H., & Haghi, M. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230607124803 · Cited by 2
Shao, M., Gao, L., Xu, J., Zhu, L., Lu, Y., Jiang, K., Sun, J., Jiang, X., Jia, L., Zhang, A., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118113 · Cited by 2
Epigenetics-based treatment strategies for Alzheimer’s disease
Cao, Q., Wang, W., & Yan, Z. (2022) · Aging · doi:10.18632/aging.204096 · Cited by 2
Self-citationEpigenetic regulations in neurological disorders
Mondal, P., Sarkar, S., & Das, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823931-5.00010-4 · Cited by 2
Cell type-specific master metabolic regulators of Alzheimer’s diseasePreprint
Qiu, Y., Hou, Y., Wetzel, L., Caldwell, J., Zhu, X., Pieper, A. A., Liu, T., & Cheng, F. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.11.664443 · Cited by 2
Zhong, P., Cao, Q., & Yan, Z. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231413 · Cited by 1
Self-citationPersonalized epigenetics of neurodegenerative diseases
Gautam, V., Sandhu, A., Rawat, K., Kumar, A., & Saha, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23802-4.00020-x · Cited by 1
Sehati, F., Hosseindoost, S., Ranjbaran, M., Nabavizadeh, F., Karimian, S. M., Adeli, S., Zahedi, E., Chodari, L., & Ashabi, G. (2024) · Drug Development Research · doi:10.1002/ddr.70001 · Cited by 1
Alzheimer’s Disease and Epigenetics
Örenay-Boyacıoğlu, S., Boyacioglu, O., & Döndü, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_172 · Cited by 1
Epigenomic profile of GBA1 in Parkinson’s disease
Berson, E., Zaghroun, R., Santoro, M., Bukhari, S., Seong, D., Shu, C.-H., Perna, A., James, T., Montine, K., Serrano, G., et al. (2025) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2025.108066 · Cited by 1
Yeasmin, A., & Torrente, M. P. (2025) · Biology · doi:10.3390/biology14111556 · Cited by 1
Epigenomics of neurological disorders
Khorkova, O., Hsiao, J. H., & Wahlestedt, C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00003-9 · Cited by 1
Facile synthesis of photoactivatable adenosine analogs
White, D. S., Mongeluzi, D. V., Curry, A. M., Donu, D., & Cen, Y. (2022) · RSC Advances · doi:10.1039/d1ra08794k · Cited by 1
Epigenetics of Alzheimer’s Disease: Past, Present and Future
Adiga, D., Eswaran, S., Sriharikrishnaa, S., Khan, N. G., Kabekkodu, S. P., & Kumar, D. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815136142123010005 · Cited by 1
Systematic characterization of cell type-specific master metabolic regulators in Alzheimer's diseasePreprint
Cheng, F., Qiu, Y., Hou, Y., Wetzel, L. W., Caldwell, J., Zhu, X., Liu, T., & Pieper, A. A. (2025) · Research Square · doi:10.21203/rs.3.rs-7207381/v1 · Cited by 1
Hoshide, R., & Jandial, R. (2019) · Neurosurgery · doi:10.1093/neuros/nyz173
Patent Highlights June–July 2021
Mucke, H. A. (2021) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2021-0022
Epigenetics and cognitive disorders
Stoccoro, A., & Coppedè, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823577-5.00032-5
The influence of epigenetic factors on the development of Alzheimer`s and Parkinson`s diseases
Sultan, K., Gantsa, A., Shomanov, A., Saulet, O., & Kerimova, A. (2023) · InterConf · doi:10.51582/interconf.19-20.10.2023.019
Epigenetics and cognitive disorders—translational aspects
Coppedè, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18516-8.00016-8
Yang, L., Zhu, K., Li, N., Wang, X., Xiao, X., Li, L., Li, L., He, Y., Zhang, J., Wo, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14782731
Self-citationYang, L., Zhu, K., Li, N., Wang, X., Xiao, X., Li, L., Li, L., He, Y., Zhang, J., Wo, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14782728
Self-citationHistone Lysine Methyltransferases
O’Donovan, D. H., Hsu, J. J., Liu, H., & Read, J. A. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837674916-00307
Drug Discovery for Chromatin Readers, Writers, Erasers, Remodelers and Epitranscriptomic Targets
(2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837674916-part3
Epigenomics of neurological disorders
Khorkova, O., & Wahlestedt, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00012-1
Fuchs, D.-T. S., Vit, J., Rentsendorj, A., Sheyn, J., Shi, H., Koronyo, Y., Chepurna, O. M., Davis, M. R., Wilson, J. W., Schneider, L. S. S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.15.618518
Epigenetics and pharmacoepigenetics of age-related neurodegenerative disorders
Cacabelos, R., Martínez-Iglesias, O. A., Cacabelos, N., Cacabelos, P., & Naidoo, V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-18722-3.00032-3
Mannan, A., Javaid, I., Shahid, I., Nawab, S. A., & Ashraf, M. (2025) · Journal of medical & health sciences review. · doi:10.62019/pjrzkd40
Crans, R. A. J., Fructuoso, M., Cardozo, K., Recaioglu, H., Sotelo-Fonseca, J., Vermeiren, Y., Strydom, A., Dam, D. V., Deyn, P. P. D., Rodríguez-Martín, B., et al. (2026) · npj Dementia · doi:10.1038/s44400-026-00075-x
Murray, T. N. (2023) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/k7pd-q064
Li, Y., Zhu, K., Li, N., Wang, X., Xiao, X., Li, L., Li, L., He, Y., Zhang, J., Wo, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14782725
Self-citationLin, Y., Lin, A., Cai, L., Huang, W., Yan, S., Wei, Y., Ruan, X., Fang, W., Dai, X., Cheng, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26603815
Self-citationLin, Y., Lin, A., Cai, L., Huang, W., Yan, S., Wei, Y., Ruan, X., Fang, W., Dai, X., Cheng, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26603812
Self-citationLin, Y., Lin, A., Cai, L., Huang, W., Yan, S., Wei, Y., Ruan, X., Fang, W., Dai, X., Cheng, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26603818
Self-citationLin, Y., Lin, A., Cai, L., Huang, W., Yan, S., Wei, Y., Ruan, X., Fang, W., Dai, X., Cheng, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26603821
Self-citationLin, Y., Lin, A., Cai, L., Huang, W., Yan, S., Wei, Y., Ruan, X., Fang, W., Dai, X., Cheng, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26603824
Self-citationWen, S., Huang, Y., Mu, Y., Li, C., Xu, B., Zou, S., Wei, C., Lin, K., Wu, T., Zhang, P., et al. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1834102
Histone modification dynamics in brain aging: unlocking therapeutic potential
Chang, B., Yang, S., Yilixiati, A., Zhang, F. Z., Sun, X., Wang, L., Hu, B., & Zhou, Y. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08917-5
Self-citationReduced expression of Brain Expressed X-linked genes in Alzheimer's disease
Li, L., Kenner, E., Wan, L., Yan, Z., & Feng, J. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261471446
Self-citationEpigenetic mechanisms in brain development and in neurodegeneration
MA, Y., CHEN, K. W., & JAGER, P. D. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19043-8.00030-x
Fuchs, D.-T. S., Vit, J., Rentsendorj, A., Koronyo, Y., Sheyn, J., Gaire, B. P., Shahin, S., Shi, H., Chepurna, O. M., Davis, M. R., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71918
BindingDB Entry 50016506: Discovery of the First-in-Class G9a/GLP Covalent Inhibitors.
BindingDB (2023) · UC San Diego · doi:10.7270/q26t0rpt
Liang, J., Cao, H., 任秀敏, Sha, N., Han, X., Jiang, L., Liu, B., & Zhao, W. (2026) · Aging Cell · doi:10.1111/acel.70785
Shan, Q., Li, J., Wang, Y., Gupta, S., Song, L., Zhang, W., Su, F., & Guo, Y. (2026) · iScience · doi:10.1016/j.isci.2026.118073
Metadata
- Authors
- Zheng, Y., Liu, A., Wang, Z.-J., Cao, Q., Wang, W., Lin, L., Ma, K., Zhang, F., Wei, J., Matas, E., Cheng, J., Chen, G.-J., Wang, X., & Yan, Z.
- Affiliations
- Capital Medical University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA
- University at Buffalo, State University of New York (US)
- VA Western New York Healthcare System (US)
- Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, P.R.China
- Corresponding author
- Zheng, Yan
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-01-22
- Volume
- 142
- Issue
- 3
- Pages
- 787-807
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6391616
- OpenAlex
- W2914500235
- Cited by
- 168
- References
- 73
- Citations by year
- 2026: 12 · 2025: 26 · 2024: 38 · 2023: 25 · 2022: 29 · 2021: 18 · 2020: 13 · 2019: 7
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- VA Merit (I01BX001633)
- National Institutes of Health (R01-AG056060)
- National Key Research and Development Program of China (2016YFC1306300, 81571038, 81771145)
- NSFC (81171197, 81220108010)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, EHMT1, G9a, H3K9me2, histone methylation, epigenetic dysregulation, glutamate receptors, AMPA receptors, NMDA receptor, synaptic function, prefrontal cortex, hippocampus, memory impairment, gene transcription
- MeSH terms
- Alzheimer Disease, Animals, Chromosome Deletion, Cognition, Cognition Disorders, Disease Models, Animal, Hippocampus, Histocompatibility Antigens, Histones, Humans, Lysine, Memory Disorders, Methylation, Mice, Transgenic, Histone-Lysine N-Methyltransferase, Synapses, Prefrontal Cortex, DNA Methylation, Epigenesis, Genetic, Mice, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.